Articles avec comité de lecture de revues internationales

31 - 

Incidence, characteristics, and mortality of infective endocarditis in France in 2011

Simon Sunder, Leslie Grammatico-Guillon, Adrien Lemaignen, Marion Lacasse, Christophe Gaborit, David Boutoille, Pierre Tattevin, Eric Denes, Thomas Guimard, Mathieu Dupont, Laurent Fauchier, Louis Bernard

PLoS ONE, 2019, 14 (10), e0223857.

DOI : https://doi.org/10.1371/journal.pone.0223857

Pubmed : 31652280

 

32 - 

Risk factors and prognostic impact of left ventricular assist device–associated infections

Pierre Tattevin, Erwan Flécher, Vincent Auffret, Christophe Leclercq, Stéphane Boulé, V. V.elli, Camille Dambrin, Clément Delmas, Laurent Barandon, Vincent Veniard, Michel Kindo, Thomas Cardi, Philippe Gaudard, Arnaud Rouvière, Thomas Sénage et al.

American Heart Journal, 2019, 214, 69-76.

DOI : https://doi.org/10.1016/j.ahj.2019.04.021

Pubmed : 31174053

 

33 - 

Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: Insights From Real Life

Pierre Tattevin, Matthieu Revest

Clinical Infectious Diseases, 2019, 69 (10), 1701-1702.

DOI : https://doi.org/10.1093/cid/ciz027

Pubmed : 30649207

 

34 - 

Mycobacterium tuberculosis prosthetic joint infections a case series and literature review

Fabrice Uhel, Gregory Corvaisier, Yves Poinsignon, Catherine Chirouze, Guillaume Béraud, Olivier Grossi, Nicolas Varache, Cédric Arvieux, Rozenn Le Berre, Pierre Tattevin

Journal of Infection, 2019, 78 (1), 27-34.

DOI : https://doi.org/10.1016/j.jinf.2018.08.008

Pubmed : 30138639

 

35 - 

Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii

Gregory A. Knauf, Ashley L. Cunningham, Misha I. Kazi, Ian M. Riddington, Alexander A. Crofts, Vincent Cattoir, M. Stephen Trent, Bryan W. Davies

mBio, 2018, 9 (1), e02394-17. ⟨10.1128/mBio.02394-17⟩.

DOI : https://doi.org/10.1128/mBio.02394-17

Pubmed : 29437928

 

36 - 

Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli

M Berleur, F Guérin, L Massias, F. Chau, J Poujade, V Cattoir, B Fantin, V de Lastours

Journal of Antimicrobial Chemotherapy, 2018, 73 (11), 3074-3080.

DOI : https://doi.org/10.1093/jac/dky283

Pubmed : 30085154

 

37 - 

Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure observations in an in vivo mouse model of prosthetic vascular material infections

Rym Boudjemaa, Karine K. Steenkeste, Cédric Jacqueline, Romain Briandet, Jocelyne Caillon, David Boutoille, Virginie Le Mabecque, Pierre Tattevin, Marie-Pierre Fontaine-Aupart, Matthieu Revest

Journal of Antimicrobial Chemotherapy, 2018, 73 (9), pp.2418-2421. ⟨hal-01834453v2⟩

DOI : https://doi.org/10.1093/jac/dky205

Pubmed : 29901764

 

38 - 

Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial

Charles Burdet, Paul Loubet, Vincent Le Moing, William Vindrios, Marina Esposito-Farèse, Morgane Linard, Tristan Ferry, Laurent Massias, Pierre Tattevin, Michel Wolff, François Vandenesch, Nathalie Grall, Caroline Quintin, France Mentré, Xavier Marie Duval et al.

BMJ Open, 2018, 8 (8), e023151.

DOI : https://doi.org/10.1136/bmjopen-2018-023151

Pubmed : 30173161

 

39 - 

How is fosfomycin resistance developed in Escherichia coli?

Vincent Cattoir, Francois Guerin

Future Microbiology, 2018, 13 (16), 1693-1696.

DOI : https://doi.org/10.2217/fmb-2018-0294

Pubmed : 30526061

 

40 - 

Bacterial adaptation to antibiotics through regulatory RNAs

Brice Felden, Vincent Cattoir

Antimicrobial Agents and Chemotherapy, 2018, 62 (5), e02503-17.

DOI : https://doi.org/10.1128/AAC.02503-17

Pubmed : 29530859